RNS Number : 0945Z
Hikma Pharmaceuticals Plc
24 May 2016
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and
Connected Persons
All relevant boxes should be completed in block capital letters.
|
1.
|
Name of the issuer
HIKMA PHARMACEUTICALS PLC
|
2.
|
State whether the notification relates to (i) a
transaction notified in accordance with DTR 3.1.2 R,
(ii) a disclosure made in accordance
LR 9.8.6R(1) or
(iii) a disclosure made in accordance with section 793 of the Companies Act
(2006).
(i) & (iii)
|
|
|
|
|
|
|
3.
|
Name of person discharging managerial
responsibilities/director
KHALID NABILSI
|
4.
|
State whether notification relates to a person
connected with a person discharging managerial responsibilities/director named in 3 and
identify the connected person
N/A
|
|
|
|
|
|
|
5.
|
Indicate whether the notification is in respect of a holding of the person referred to in 3
or 4 above or in respect of a nonbeneficial
interest 1
3 ABOVE
|
6.
|
Description of shares (including class), debentures or derivatives or financial instruments
relating to shares
ORDINARY SHARES OF 10P EACH
|
|
|
|
|
|
|
7.
|
Name of registered shareholders(s) and, if more than one, the number of shares held by each
of them
FOREST NOMINEES LIMITED
|
8.
|
State the nature of the transaction
DISPOSAL OF 20,000 SHARES.
|
|
|
|
|
|
|
9.
|
Number of shares, debentures or financial
instruments relating to shares acquired
N/A
|
10.
|
Percentage of issued class acquired (treasury shares of that class should not be taken into
account when calculating percentage)
N/A
|
|
|
|
|
|
|
11.
|
Number of shares, debentures or financial
instruments relating to shares disposed
20,000
|
12.
|
Percentage of issued class disposed (treasury shares of that class should not be taken into
account when calculating percentage)
0.01%
|
|
|
|
|
|
|
13.
|
Price per share or value of transaction
£22.85
|
14.
|
Date and place of transaction
23 MAY 2016, LONDON
|
|
|
|
|
|
|
15.
|
Total holding following notification and total percentage holding following notification
(any treasury shares should not be taken into account when calculating percentage)
201,921 (0.08%)
|
16.
|
Date issuer informed of transaction
23 MAY 2016
|
|
|
|
|
|
If a person discharging managerial responsibilities has been granted options by the
issuer
complete the following boxes
|
17.
|
Date of grant
N/A
|
18.
|
Period during which or date on which exercisable
N/A
|
|
|
|
|
|
|
19.
|
Total amount paid (if any) for grant of the option
N/A
|
20.
|
Description of shares or debentures involved (class and number)
N/A
|
|
|
|
|
|
|
21.
|
Exercise price (if fixed at time of grant) or
indication that price is to be fixed at the time of exercise
N/A
|
22.
|
Total number of shares or debentures over which options held following
notification
N/A
|
|
|
|
|
|
|
23.
|
Any additional information
N/A
|
24.
|
Name of contact and telephone number for queries
PETER SPEIRS 0207 399 2772
|
|
|
|
|
|
|
Name of authorised official of issuer responsible for making notification
Peter Speirs, Company Secretary
Date of notification 24 May 2016
|
Notes: This form is intended for use by an issuer to make a RIS notification
required by DR 3.3.
|
(1)
|
An issuer making a notification in respect of a transaction relating to the shares or
debentures of the issuer should complete boxes 1 to 16, 23 and 24.
|
|
(2)
|
An issuer making a notification in respect of a derivative relating the shares of the
issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGUGDURBDBGLS